Drug Shortage Report for HALOPERIDOL INJECTION, USP
| Report ID | 105501 |
| Drug Identification Number | 02406411 |
| Brand name | HALOPERIDOL INJECTION, USP |
| Common or Proper name | Haloperidol Injection |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | HALOPERIDOL |
| Strength(s) | 5MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR |
| Packaging size | 1 ml |
| ATC code | N05AD |
| ATC description | ANTIPSYCHOTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-02-07 |
| Estimated end date | 2020-04-13 |
| Actual end date | 2020-04-13 |
| Shortage status | Resolved |
| Updated date | 2020-04-14 |
| Company comments | Fresenius Kabi Canada Ltd. is pleased to advise that replenishment inventories of our Haloperidol Injection, USP 5 mg/mL MD Vial 1 mL will be available at all distribution centres on Monday, April 13th, 2020. Please note that the product will be placed on 150% allocation. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2020-04-14 | French | Compare |
| v6 | 2020-04-14 | English | Compare |
| v5 | 2020-04-07 | French | Compare |
| v4 | 2020-04-07 | English | Compare |
| v3 | 2020-02-08 | English | Compare |
| v2 | 2020-02-07 | French | Compare |
| v1 | 2020-02-07 | English | Compare |
Showing 1 to 7 of 7